{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:30:05Z","timestamp":1786609805307,"version":"build-2736575974"},"reference-count":188,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Autoimmune diseases (ADs) are a group of inflammatory disorders triggered by aberrant immune responses against autoantigens and the breakdown of immune tolerance. Current therapeutic strategies, such as glucocorticoids and immunosuppressants, exert largely non-specific immunomodulation and are frequently associated with substantial adverse effects upon long-term administration. As such, these approaches are often insufficient to re-establish immune homeostasis. In recent years, regulatory T cell (Treg)-based therapeutics have undergone rapid advancement, with continuously updated therapeutic modalities broadening the application boundary of immune tolerance intervention. This review comprehensively outlines the progress of Treg-based therapeutics, spanning from fundamental biological research to translational applications in autoimmune diseases. We describe the developmental characteristics, suppressive machinery, and heterogeneity of Tregs, and highlight the preclinical and clinical advancements of diverse Treg therapeutic modalities, including polyclonal and antigen-specific Tregs, TCR-engineered Tregs, and CAR-Tregs. Furthermore, we emphasize current optimization strategies for enhancing Treg stability, antigen specificity, and\n                    <jats:italic>in vivo<\/jats:italic>\n                    fitness within inflammatory microenvironments. Additionally, we objectively address the major translational bottlenecks of Treg therapy and provide future perspectives to facilitate the clinical implementation of Treg-based immunotherapies for autoimmune diseases.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1881360","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:59:42Z","timestamp":1786607982000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory T cells in autoimmune diseases: biological mechanisms, clinical translation, and translational challenges"],"prefix":"10.3389","volume":"17","author":[{"given":"Jingchang","family":"Li","sequence":"first","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine","place":["Kaifeng, China"]},{"name":"School of Basic Medical Sciences, Henan University School of Medicine","place":["Kaifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Pang","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine","place":["Kaifeng, China"]},{"name":"School of Basic Medical Sciences, Henan University School of Medicine","place":["Kaifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Wu","sequence":"additional","affiliation":[{"name":"Eye Institute of Shandong First Medical University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine","place":["Kaifeng, China"]},{"name":"School of Basic Medical Sciences, Henan University School of Medicine","place":["Kaifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun J.","family":"Zheng","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine","place":["Kaifeng, China"]},{"name":"School of Basic Medical Sciences, Henan University School of Medicine","place":["Kaifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Ruan","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine","place":["Kaifeng, China"]},{"name":"School of Basic Medical Sciences, Henan University School of Medicine","place":["Kaifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Liu","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine","place":["Kaifeng, China"]},{"name":"School of Basic Medical Sciences, Henan University School of Medicine","place":["Kaifeng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365554","article-title":"Emerging role of gut microbiota in autoimmune diseases","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: An update","volume":"23","author":"Arnaud","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid arthritis: advances in treatment strategies","volume":"478","author":"Prasad","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05306-5","article-title":"Current treatment of systemic lupus erythematosus: a clinician\u2019s perspective","volume":"43","author":"Katarzyna","year":"2023","journal-title":"Rheumatol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1996.0026","article-title":"T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases","volume":"9","author":"Sakaguchi","year":"1996","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/3-540-27702-1_3","article-title":"Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection","volume":"293","author":"Coutinho","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1090105","article-title":"Comment on \u201cExpression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"185","author":"Verhagen","year":"2010","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-377895","article-title":"Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion","volume":"119","author":"Kim","year":"2012","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120822","article-title":"Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo","volume":"209","author":"Yadav","year":"2012","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216432","article-title":"Regulatory T cells in the pathogenesis of graves\u2019 Disease","volume":"24","author":"Kustrimovic","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500020","article-title":"IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance","volume":"194","author":"Han","year":"2015","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.49","article-title":"The IL-33\/ST2 axis is specifically required for development of adipose tissue-resident regulatory T cells","volume":"12","author":"Hu","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.74","article-title":"Foxp3(+) T cells expressing ROR\u03b3t represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation","volume":"9","author":"Yang","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","article-title":"Tissue regulatory T cells: regulatory chameleons","volume":"21","author":"Mu\u00f1oz-Rojas","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-24-01363","article-title":"Regulatory T cells in neurological disorders and tissue regeneration: Mechanisms of action and therapeutic potentials","volume":"21","author":"Jie","year":"2026","journal-title":"Neural Regener Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070109","article-title":"CREB\/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation","volume":"204","author":"Kim","year":"2007","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-010-0642-1","article-title":"Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells","volume":"88","author":"Polansky","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3646","article-title":"Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment","volume":"18","author":"Kitagawa","year":"2017","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1328193","article-title":"Mechanisms underlying immunosuppression by regulatory cells","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X21500300","article-title":"CD39\/CD73\/A2a adenosine metabolic pathway: targets for moxibustion in treating DSS-induced ulcerative colitis","volume":"49","author":"Zhu","year":"2021","journal-title":"Am J Chin Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1387975","article-title":"Regulation of Treg cells by cytokine signaling and co-stimulatory molecules","volume":"15","author":"Zong","year":"2024","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03242.x","article-title":"T regulatory cells and their counterparts: masters of immune regulation","volume":"39","author":"Ozdemir","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4752","article-title":"Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells","volume":"181","author":"Gondek","year":"2008","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.162580","article-title":"Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1","volume":"7","author":"Klaus","year":"2022","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.12.004","article-title":"Gene-corrected regulatory T cell therapy for IL2RA deficiency","volume":"34","author":"Ha","year":"2026","journal-title":"Mol Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1038\/s41467-025-59626-0","article-title":"Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset","volume":"16","author":"Golden","year":"2025","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200251","article-title":"Alterations of thymus-derived tregs in multiple sclerosis","volume":"11","author":"Lorenzini","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111606","article-title":"Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus","volume":"41","author":"Guo","year":"2022","journal-title":"Cell Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12974-024-03095-7","article-title":"Thymic gene expression analysis reveals a potential link between HIF-1A and Th17\/Treg imbalance in thymoma associated myasthenia gravis","volume":"21","author":"Alt\u0131n\u00f6nder","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127417","article-title":"Pathogenesis and treatment of Sjogren\u2019s syndrome: Review and update","volume":"14","author":"Zhan","year":"2023","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626193","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106888","article-title":"Dysregulated Th17\/Treg cell axis is correlated with local and systemic immune response in human intermediate uveitis","volume":"268","author":"Saini","year":"2024","journal-title":"Immunol Lett"},{"key":"B52","doi-asserted-by":"publisher","first-page":"151849","DOI":"10.1016\/j.imbio.2019.09.008","article-title":"IBD: Role of intestinal compartments in the mucosal immune response","volume":"225","author":"Iacomino","year":"2020","journal-title":"Immunobiology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601409","article-title":"Activation and functional specialization of regulatory T cells lead to the generation of Foxp3 instability","volume":"198","author":"Zhang","year":"2017","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319828530","article-title":"Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis","volume":"28","author":"Zhu","year":"2019","journal-title":"Lupus"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162306","article-title":"The proportion of regulatory T cells in patients with rheumatoid arthritis: a meta-analysis","volume":"11","author":"Morita","year":"2016","journal-title":"PloS One"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1292158","article-title":"Characterizing Foxp3+ and Foxp3- T cells in the homeostatic state and after allo-activation: resting CD4+Foxp3+ Tregs have molecular characteristics of activated T cells","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.730614","article-title":"Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3","volume":"54","author":"Dasgupta","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109824","article-title":"Blood regulatory T cells in inflammatory bowel disease, a systematic review, and meta-analysis","volume":"117","author":"Jalalvand","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1565133","article-title":"Restoring immune tolerance in pre-RA: immunometabolic dialogue between gut microbiota and regulatory T cells","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744763","article-title":"Polyclonal regulatory T cell manufacturing under cGMP: a decade of experience","volume":"12","author":"Balcerek","year":"2021","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604483","article-title":"Treg cell therapy manufacturability: current state of the art, challenges and new opportunities","volume":"16","author":"Stoops","year":"2025","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.11.7135","article-title":"CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells","volume":"175","author":"DiPaolo","year":"2005","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041033","article-title":"Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node","volume":"202","author":"Samy","year":"2005","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501723","article-title":"Treatment of uveitis by in situ administration of ex vivo-activated polyclonal regulatory T cells","volume":"196","author":"Gr\u00e9goire","year":"2016","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2023.213496","article-title":"Regulatory T cell intravitreal delivery using hyaluronan methylcellulose hydrogel improves therapeutic efficacy in experimental autoimmune uveitis","volume":"151","author":"Zhang","year":"2023","journal-title":"Biomater Adv"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.8.3939","article-title":"Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells","volume":"170","author":"Mottet","year":"2003","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003617","article-title":"Ex vivo expanded donor alloreactive regulatory T cells lose immunoregulatory, proliferation, and antiapoptotic markers after infusion into ATG-lymphodepleted, nonhuman primate heart allograft recipients","volume":"105","author":"Ezzelarab","year":"2021","journal-title":"Transplantation"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221149444","article-title":"CD27-expressing xenoantigen-expanded human regulatory T cells are efficient in suppressing xenogeneic immune response","volume":"32","author":"Cao","year":"2023","journal-title":"Cell Transplant"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1084\/jem.20061631","article-title":"Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice","volume":"204","author":"Tarbell","year":"2007","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41467-024-45056-x","article-title":"Smith-specific regulatory T cells halt the progression of lupus nephritis","volume":"15","author":"Eggenhuizen","year":"2024","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.01.005","article-title":"Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti-glomerular basement membrane disease antigen","volume":"107","author":"Eggenhuizen","year":"2025","journal-title":"Kidney Int"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1716","article-title":"Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models","volume":"14","author":"Yang","year":"2022","journal-title":"Sci Transl Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262311563","article-title":"TCR-based antigen-specific therapy for type 1 diabetes mellitus: from editing autoreactive clones to tolerance induction","volume":"26","author":"Fisher","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.05.003","article-title":"Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells","volume":"92","author":"Kim","year":"2018","journal-title":"J Autoimmun"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2023.1184937","article-title":"CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions","volume":"3","author":"Abraham","year":"2023","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02359","article-title":"Chimeric antigen receptor (CAR) Treg: a promising approach to inducing immunological tolerance","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07511-0","article-title":"Harnessing the inherent power of chimeric antigen receptor (CAR)-expressing regulatory T cells (CAR-Tregs) to treat autoimmune-related disorders","volume":"49","author":"Kahmini","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168601","article-title":"Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice","volume":"133","author":"Spanier","year":"2023","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1177\/15209156251403551","article-title":"Antigen-specific chimeric antigen receptor-T regulatory cells home to human islets, suppress cytotoxic T lymphocytes and reverse type 1 diabetes","volume":"28","author":"Imam","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J Neuroinflamm"},{"key":"B86","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12974-024-03262-w","article-title":"MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis","volume":"21","author":"Frikeche","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1172\/JCI182480","article-title":"Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusion","volume":"135","author":"McDonald-Hyman","year":"2025","journal-title":"J Clin Invest"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175897","article-title":"Lactate supports Treg function and immune balance via MGAT1 effects on N-glycosylation in the mitochondria","volume":"134","author":"Zhou","year":"2024","journal-title":"J Clin Invest"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219086120","article-title":"Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion","volume":"120","author":"Lamarche","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00268","article-title":"Competition for IL-2 between regulatory and effector T cells to chisel immune responses","volume":"3","author":"H\u00f6fer","year":"2012","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030459","article-title":"Novel scFv against Notch ligand JAG1 suitable for development of cell therapies toward JAG1-positive tumors","volume":"13","author":"Silva","year":"2023","journal-title":"Biomolecules"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106329","article-title":"Locoregional delivery of CAR-T cells in the clinic","volume":"182","author":"Sagnella","year":"2022","journal-title":"Pharmacol Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl4793","article-title":"Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs","volume":"386","author":"Reddy","year":"2024","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1511671","article-title":"T-regulatory cells for the treatment of autoimmune diseases","volume":"16","author":"Fisher","year":"2025","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2023.1184937","article-title":"CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions","volume":"3","author":"Abraham","year":"2023","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01608","article-title":"The future of regulatory T cell therapy: promises and challenges of implementing CAR technology","volume":"11","author":"Mohseni","year":"2020","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1267762","article-title":"Unlocking the potential of Tregs: innovations in CAR technology","volume":"10","author":"Requejo Cier","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1746673","article-title":"Smart control of CAR-T cells: emerging strategies for safer and more effective cancer immunotherapy","volume":"17","author":"Zhang","year":"2026","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171844","article-title":"GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes","volume":"9","author":"Uenishi","year":"2024","journal-title":"JCI Insight"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw2707","article-title":"Conversion of antigen-specific effector\/memory T cells into Foxp3-expressing Treg cells by inhibition of CDK8\/19","volume":"4","author":"Akamatsu","year":"2019","journal-title":"Sci Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr6049","article-title":"Generating functionally stable and antigen-specific Treg cells from effector T cells for cell therapy of inflammatory diseases","volume":"17","author":"Mikami","year":"2025","journal-title":"Sci Transl Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701502","article-title":"IL-2-anti-IL-2 monoclonal antibody immune complexes inhibit collagen-induced arthritis by augmenting regulatory T cell functions","volume":"201","author":"Yokoyama","year":"2018","journal-title":"J Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111478","article-title":"Engineered human cytokine\/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection","volume":"41","author":"VanDyke","year":"2022","journal-title":"Cell Rep"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082824","article-title":"In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression","volume":"206","author":"Webster","year":"2009","journal-title":"J Exp Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101234","article-title":"IL-2 therapy diminishes renal inflammation and the activity of kidney-infiltrating CD4+ T cells in murine lupus nephritis","volume":"8","author":"Rose","year":"2019","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01106","article-title":"Defining the threshold IL-2 signal required for induction of selective Treg cell responses using engineered IL-2 muteins","volume":"11","author":"Ghelani","year":"2020","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03136","article-title":"Molecular mechanisms controlling Foxp3 expression in health and autoimmunity: From epigenetic to post-translational regulation","volume":"10","author":"Colamatteo","year":"2019","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2023.2274574","article-title":"Low-dose IL-2 therapy in autoimmune diseases: An update review","volume":"43","author":"Zhang","year":"2024","journal-title":"Int Rev Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","article-title":"Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model","volume":"705","author":"Li","year":"2019","journal-title":"Neurosci Lett"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000769","article-title":"Combined administration of a mutant TGF-beta1\/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance","volume":"185","author":"Zhang","year":"2010","journal-title":"J Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113898","article-title":"Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulation","volume":"176","author":"Yang","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155568","article-title":"Natural plant medications for the treatment of retinal diseases: The blood-retinal barrier as a clue","volume":"130","author":"Ren","year":"2024","journal-title":"Phytomedicine"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111291","article-title":"Longdan Xiegan decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation","volume":"136","author":"Yin","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.03.013","article-title":"Kurarinone regulates Th17\/Treg balance and ameliorates autoimmune uveitis via Rac1 inhibition","volume":"69","author":"Gu","year":"2025","journal-title":"J Adv Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177571","article-title":"Sinomenine alleviates experimental autoimmune uveitis in rats: Possible involvement of PI3K\/AKT and NF-\u03baB signaling pathways","volume":"996","author":"Gao","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/nu17050897","article-title":"Yerba mate (Ilex paraguariensis) ameliorates experimental autoimmune encephalomyelitis by modulating regulatory T cell function","volume":"17","author":"Herrada","year":"2025","journal-title":"Nutrients"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.12.28","article-title":"Therapeutic effects of upadacitinib on experimental autoimmune uveitis: Insights from single-cell analysis","volume":"64","author":"Huang","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.3.30","article-title":"Antimetabolite drugs exhibit distinctive immunomodulatory mechanisms and effects on the intestinal microbiota in experimental autoimmune uveitis","volume":"63","author":"Lloren\u00e7","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41467-023-36594-x","article-title":"Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming","volume":"14","author":"Aso","year":"2023","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.14.23","article-title":"Itaconate Ameliorates Experimental Autoimmune Uveitis by Modulating Teff\/Treg Cell Imbalance Via the DNAJA1\/CDC45 Axis","volume":"65","author":"Jiang","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B123","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12974-023-02829-3","article-title":"Progesterone attenuates Th17-cell pathogenicity in autoimmune uveitis via Id2\/Pim1 axis","volume":"20","author":"Liu","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12204","article-title":"Potential utility of melatonin as an antioxidant therapy in the management of sickle cell anemia","volume":"58","author":"da Silva","year":"2015","journal-title":"J Pineal Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12525","article-title":"Melatonin and inflammation-story of a double-edged blade","volume":"65","author":"Hardeland","year":"2018","journal-title":"J Pineal Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-022-02477-z","article-title":"Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species\/TXNIP\/HIF-1\u03b1 axis to alleviate autoimmune uveitis","volume":"19","author":"Huang","year":"2022","journal-title":"J Neuroinflamm"},{"key":"B127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","article-title":"Ketogenic diet for human diseases: The underlying mechanisms and potential for clinical implementations","volume":"7","author":"Zhu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B128","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41392-021-00549-9","article-title":"Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome","volume":"6","author":"Kong","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B129","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12974-024-03308-z","article-title":"Ketogenic diet modulates immune cell transcriptional landscape and ameliorates experimental autoimmune uveitis in mice","volume":"21","author":"Duan","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115666","article-title":"A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis","volume":"168","author":"Qin","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B131","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00125-024-06329-8","article-title":"Inhibition of CD226 co-stimulation suppresses diabetes development i the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function","volume":"68","author":"Brown","year":"2025","journal-title":"Diabetologia"},{"key":"B132","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-pharmtox-010611-134715","article-title":"Therapeutic targeting of the interleukin-6 receptor","volume":"52","author":"Tanaka","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12985-024-02286-1","article-title":"Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma","volume":"21","author":"Hadi","year":"2024","journal-title":"Virol J"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.34133\/research.0291","article-title":"AAV for gene therapy in ocular diseases: Progress and prospects","volume":"6","author":"He","year":"2023","journal-title":"Res (Wash D C)"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2025.110273","article-title":"Recombinant adeno-associated virus with anti-tumor necrosis factor-alpha in an experimental autoimmune uveitis model","volume":"253","author":"Li","year":"2025","journal-title":"Exp Eye Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1042\/CS20201544","article-title":"Murine endometrial-derived mesenchymal stem cells suppress experimental autoimmune encephalomyelitis depending on indoleamine-2,3-dioxygenase expression","volume":"135","author":"Manganeli Polonio","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S525394","article-title":"MSC-derived extracellular vesicles: Roles and molecular mechanisms for tissue repair","volume":"20","author":"Wu","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"B139","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/cei.12080","article-title":"The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis","volume":"173","author":"Li","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13287-024-03764-7","article-title":"Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis","volume":"15","author":"Duan","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B141","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13287-022-02780-9","article-title":"Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150212","article-title":"Topical ophthalmic instillation of engineered hMSCs-derived exosomes: A novel non-invasive therapeutic strategy for ocular posterior-segment disorder","volume":"723","author":"Yang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12361","article-title":"Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders","volume":"12","author":"Huang","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404064","article-title":"3D-hUMSCs exosomes ameliorate vitiligo by simultaneously potentiating Treg cells-mediated immunosuppression and suppressing oxidative stress-induced melanocyte damage","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415712","article-title":"Engineered Foxp1high exosomes ameliorates systemic lupus erythematosus","volume":"12","author":"Niu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B146","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s13287-022-03174-7","article-title":"Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17+ regulatory T cell","volume":"13","author":"Zhang","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13040823","article-title":"Exosome-modified AAV gene therapy attenuates autoimmune hepatitis via enhanced regulatory T cell targeting and immune modulation","volume":"13","author":"Shao","year":"2025","journal-title":"Microorganisms"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2586305","article-title":"Induction of antigen-specific regulatory T cells by engineered extracellular vesicles","volume":"32","author":"Imai","year":"2025","journal-title":"Drug Delivery"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002361","article-title":"High TCR stimuli prevent induced regulatory T cell differentiation in a NF-\u03baB-dependent manner","volume":"186","author":"Molinero","year":"2011","journal-title":"J Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3233-9","article-title":"Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes","volume":"57","author":"Turner","year":"2014","journal-title":"Diabetologia"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300193","article-title":"Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance","volume":"191","author":"Khare","year":"2013","journal-title":"J Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864403","article-title":"Nanoparticles for inducing antigen-specific T cell tolerance in autoimmune diseases","volume":"13","author":"Benne","year":"2022","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0424-1","article-title":"Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes","volume":"3","author":"Wilson","year":"2019","journal-title":"Nat BioMed Eng"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-023-01086-2","article-title":"Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses","volume":"7","author":"Tremain","year":"2023","journal-title":"Nat BioMed Eng"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119432","article-title":"Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease","volume":"222","author":"Saito","year":"2019","journal-title":"Biomaterials"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add8693","article-title":"Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis","volume":"9","author":"Rhodes","year":"2023","journal-title":"Sci Adv"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103125","article-title":"Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease","volume":"140","author":"Kishimoto","year":"2023","journal-title":"J Autoimmun"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201700290","article-title":"Engineering immunological tolerance using quantum dots to tune the density of self-antigen display","volume":"27","author":"Hess","year":"2017","journal-title":"Adv Funct Mater"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2016451117","article-title":"Tolerogenic nanoparticles suppress central nervous system inflammation","volume":"117","author":"Kenison","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2009.03206.x","article-title":"Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy","volume":"129","author":"Sadegh-Nasseri","year":"2010","journal-title":"Immunology"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1126\/science.1833816","article-title":"Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand","volume":"252","author":"Evavold","year":"1991","journal-title":"Science"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.immunol.14.1.1","article-title":"Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology","volume":"14","author":"Sloan-Lancaster","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/1074-7613(95)90169-8","article-title":"An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis","volume":"3","author":"Nicholson","year":"1995","journal-title":"Immunity"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1002\/art.34372","article-title":"Superior molecularly altered influenza virus hemagglutinin peptide 308-317 inhibits collagen-induced arthritis by inducing CD4+ Treg cell expansion","volume":"64","author":"Sun","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02295-4","article-title":"Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cells","volume":"26","author":"Hu","year":"2025","journal-title":"Nat Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae135","article-title":"IL23R-specific CAR Tregs for the treatment of Crohn\u2019s disease","volume":"19","author":"Cui","year":"2025","journal-title":"J Crohns Colitis"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00232","article-title":"Peripherally induced tregs - role in immune homeostasis and autoimmunity","volume":"4","author":"Yadav","year":"2013","journal-title":"Front Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00554","article-title":"Gene therapy with regulatory T cells: a beneficial alliance","volume":"9","author":"Biswas","year":"2018","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08866-1","article-title":"Improving the efficacy of regulatory T cell therapy","volume":"62","author":"Baeten","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02031-4","article-title":"Targeted demethylation of FOXP3-TSDR enhances the suppressive capacity of STAT6-deficient inducible T regulatory cells","volume":"47","author":"Arroyo-Olarte","year":"2024","journal-title":"Inflammation"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.06.004","article-title":"Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation","volume":"19","author":"Brunstein","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1616710113","article-title":"Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes","volume":"113","author":"Tan","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.02.031","article-title":"Chemokine receptor requirements for epidermal T-cell trafficking","volume":"178","author":"Tubo","year":"2011","journal-title":"Am J Pathol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1517\/14728220902762928","article-title":"CCR9 and inflammatory bowel disease","volume":"13","author":"Koenecke","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.330605","article-title":"CXCR4 signaling in central nervous system regeneration: friend or foe","volume":"17","author":"Terheyden-Keighley","year":"2022","journal-title":"Neural Regener Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1715863","article-title":"Modulating immune response for the prevention and treatment of type 1 diabetes","volume":"17","author":"Vohidova","year":"2026","journal-title":"Front Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.893576","article-title":"A novel GMP protocol to produce high-quality Treg cells from the pediatric thymic tissue to be employed as cellular therapy","volume":"13","author":"Bernaldo-de-Quir\u00f3s","year":"2022","journal-title":"Front Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102873","article-title":"Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: a systematic review and meta-analysis of clinical trials","volume":"20","author":"Willekens","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/wo.2019.84110","article-title":"Therapy with CD4+CD25+ T regulatory cells - should we be afraid of cancer","volume":"23","author":"Gliwi\u0144ski","year":"2019","journal-title":"Contemp Oncol (Pozn)"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127- regulatory T cells preserves \u03b2-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"B184","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41586-025-08795-5","article-title":"Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3","volume":"642","author":"Chen","year":"2025","journal-title":"Nature"},{"key":"B185","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1038\/s41467-025-64945-3","article-title":"HLA matching or CRISPR editing of HLA class I\/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model","volume":"16","author":"McCallion","year":"2025","journal-title":"Nat Commun"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2025.01.005","article-title":"Ligand-restricted synNotch switches enable precision cell therapy","volume":"46","author":"Li","year":"2025","journal-title":"Trends Immunol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx7845","article-title":"Armored human CAR Treg cells with PD1 promoter-driven IL-10 have enhanced suppressive function","volume":"11","author":"Boardman","year":"2025","journal-title":"Sci Adv"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3791\/54720","article-title":"Development of stem cell-derived antigen-specific regulatory T cells against autoimmunity","volume":"54720","author":"Haque","year":"2016","journal-title":"J Vis Exp"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1881360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:59:44Z","timestamp":1786607984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1881360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":188,"alternative-id":["10.3389\/fimmu.2026.1881360"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1881360","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1881360"}}